Epic teams up with Amazon Pharmacy, Eli Lilly and Mark Cuban to launch prescription drug pricing tool
Epic is bringing pharmacy price shopping directly into the doctor's office and the prescribing workflow.
Read full article →Medicare Monitor
Tracking Medicare news, policy, and coverage changes.
NABIP sues CMS over moratorium on new ACA broker registrations
The National Association of Benefits and Insurance Professionals is suing the Trump administration over its moratorium on new brokers entering the Affordable Care Act marketplaces.
Read full article →Duke Health, CaroMont Health seek to jointly build, operate 2 Charlotte-area hospitals
The pair filed Certificate of Needs with the state to build two hospitals comprising 200 beds in fast-growing North Carolina's Mecklenburg County.
Read full article →Catching up with Blue Shield of California CEO Mike Stuart one year in
In August 2025, Blue Shield of California named Mike Stuart as its CEO. Now, a year later, he's reflecting on months of work toward addressing affordability, member access and the patient journey.
Read full article →Voice AI startup careCycle rolls out free plan comparison tool for Medicare beneficiaries
The tool is free to use, takes no payments from payers or commissions and does not sell or share personal information. It surfaces yearly cost estimates and shows nearby plans that keep a patient's doctors in-network.
Read full article →Clasp launches national marketplace for loan-linked hiring
Healthcare students can use the Clasp Marketplace to compare jobs by what each one pays toward their student loans, plus salaries. In order to post a job, an employer must commit money toward a student’s debt.
Read full article →FDA advances peptide push to White House
Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to…
Read full article →AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D
Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs. Iambic also has R&D alliances with companies such as Bayer and AbbVie. The post AI…
Read full article →Trump administration advances plan for peptide drugs favored by RFK Jr.
U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections favored by health secretary Robert F. Kennedy…
Read full article →Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.
Read full article →The Trump administration is doubling down on health care fraud investigations
At the STAT Summit, the Department of Justice offered up a warning for health care executives: Don’t be another Theranos.
Read full article →Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China
Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.
Read full article →